Orizuru Therapeutics Launches Operations as Research and Development-Driven Company for Products including Induced Pluripotent Stem Cell (iPSC) Regenerative Medicine

Orizuru Therapeutics, Inc. (OZTx) announced the launch of its operations. OZTx is a research and development-driven company focusing on the development of iPSC-based regenerative medicine and the application of iPSC technology.